Volume 26, Issue 4 (Winter 2021)                   IJPCP 2021, 26(4): 418-431 | Back to browse issues page


XML Persian Abstract Print


1- Department of Educational Sciences, Faculty of Letters and Humanities, Hakim Sabzevari University, Sabzevar, Iran. , h.shareh@hsu.ac.ir
2- Department of Clinical Psychology, Faculty of Psychology and Educational Sciences, Semnan University, Semnan, Iran.
Abstract:   (3972 Views)
Objectives: The present study aims to investigate the effect of Cognitive-Behavioral Group Therapy (CBGT) on pain self-efficacy, fatigue, life expectancy and depression in patients with Multiple Sclerosis (MS).
Methods: In this quasi-experimental clinical trial with a pretest/posttest design, 68 patients with MS referred to MS clinics and MS ‎Association‎ of Razavi Khorasan Province, Iran were selected using a convenience sampling technique, and were then assigned into intervention and control groups. The intervention group received ten 2-hour weekly sessions of CBGT, while the control group received no treatment. In the pretest and posttest phases, Pain Self-Efficacy Questionnaire (PSEQ), Fatigue Severity Scale (FSS), Snyder’s ‎Adult Hope Scale (AHS)‎ ‎and Beck Depression Inventory-Second Edition (BDI-II) were completed by all subjects. The collected data were analyzed using ANCOVA and t-test.
Results: The CBGT significantly improved pain self-efficacy (P=0.001) and life expectancy (P=0.001) and reduced fatigue (P=0.02) and depression (P=0.003) in the intervention group compared to the control group.
Conclusion: CBGT can increase pain self-efficacy, life expectancy and reduce fatigue and depression in patients with MS.
Full-Text [PDF 5884 kb]   (2300 Downloads) |   |   Full-Text (HTML)  (3846 Views)  
Type of Study: Original Research | Subject: Psychiatry and Psychology
Received: 2019/08/13 | Accepted: 2020/01/13 | Published: 2021/01/1

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.